| Category |
FOCUSTM |
Differentiation |
Competitiveness |
| Target |
| Inflammatory Fibrotic |
GPCR target focused : library available for compounds targeting each Adenosine Receptor subtype |
| Cancer |
Haspin, TRK1, A2AAR, IRAK4, DYRK1 |
| Viral |
Antiviral target : SAHH, Polymerase |
|
Building up chemical libraries per Targets In accelerated manner |
Screening system customized
per disease indication |
|
|
| Hit Screening |
- Securing desirable chemical groups from nucleoside derivatives with exponential Hit ID and Optimization Rate
- Efficient Screening
|
High Hit rate Novelty and diversity |
| Novelty |
- Securing the IP Novelty of Nucleobase and sugar fragments and the structural heterogeneity
|
Assured Patentability with FM proprietary libraries |
| Diversity |
- Enhancing Fragment’s diversity by
- Connecting and Modifying Fragments
|
Securing diverse new scaffolds |
| Easy to Expand |
- Enables parallel combination of nucleobase and sugar
- pharmacophore models consisting of modified nucleotides having specific Pharmacologic target
|
Easy to Expand the asset portfolio |
